Cheng‐Wen Lin
Impact in
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- Viral Infections and Vectors
- COVID-19 Clinical Research Studies
- Pharmacology top 0.5%
- Pharmacological Effects of Natural Compounds
Papers in
-
- SARS-CoV-2 and COVID-19 Research 25
- Viral Infections and Vectors 18
-
- Infections and bacterial resistance 12
- Co-authors
- Lei WanSu‐Hua HuangYing‐Ju LinChien‐Chen LaiTsuey‐Ching YangFuu‐Jen TsaiSuh‐Chin WuChih‐Ho Lai
- Journals
- Virus Research (11 papers)Viruses (7 papers)Investigative Ophthalmology & Visual Science (7 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)Biomedicine (5 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Cheng‐Wen Lin
191 papers receiving 5.8k citations
Peers
Comparison fields: 5 of 148
- Infectious Diseases 1.4k
- Pharmacology 508
- Endocrinology 287
- Molecular Medicine 259
- Complementary and alternative medicine 413
Countries citing papers authored by Cheng‐Wen Lin
This map shows the geographic impact of Cheng‐Wen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Wen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Wen Lin more than expected).
Fields of papers citing papers by Cheng‐Wen Lin
This network shows the impact of papers produced by Cheng‐Wen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Wen Lin. The network helps show where Cheng‐Wen Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Cheng‐Wen Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 54 | |
| 6 | 2022 | 7 | |
| 7 | 2021 | 34 | |
| 8 | Ocular pharmacokinetics of a novel class of corticosteroids with ROCK inhibitory activity and potential for reduced steroid-associated risks | 2021 | 0 |
| 9 | Evaluation of the Potential of AR-13324 and AR-13503 to Induce Phospholipidosis | 2018 | 4 |
| 10 | AR-13503 Enhances the Efficacy of Aflibercept in a Mouse Model of Proliferative Diabetic Retinopathy | 2018 | 1 |
| 11 | 2016 | 2 | |
| 12 | Effectiveness of AR-13154 monotherapy and combination therapy in animal models of wet age-related macular degeneration and proliferative diabetic retinopathy | 2016 | 2 |
| 13 | 2013 | 43 | |
| 14 | 2011 | 26 | |
| 15 | 2010 | 32 | |
| 16 | 2010 | 21 | |
| 17 | IOP-Lowering Efficacy and Tolerability of AR-12286, a Potent Kinase Inhibitor for the Treatment of Glaucoma | 2009 | 3 |
| 18 | 2008 | 46 | |
| 19 | 1998 | 0 | |
| 20 | 1993 | 8 |
About Cheng‐Wen Lin
Cheng‐Wen Lin is a scholar working on Infectious Diseases, Endocrinology, Public Health, Environmental and Occupational Health, Immunology and Microbiology, having authored 197 papers that have together received 5.9k indexed citations. Recurring topics across this work include Mosquito-borne diseases and control (36 papers), SARS-CoV-2 and COVID-19 Research (25 papers), Viral Infections and Vectors (18 papers), Viral Infections and Immunology Research (16 papers), Computational Drug Discovery Methods (12 papers), Infections and bacterial resistance (12 papers), interferon and immune responses (12 papers) and Bacterial biofilms and quorum sensing (11 papers). The work is most often cited by research in Infectious Diseases (1.4k citations), Pharmacology (508 citations), Endocrinology (287 citations), Molecular Medicine (259 citations) and Complementary and alternative medicine (413 citations). Cheng‐Wen Lin has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Lei Wan, Su‐Hua Huang, Ying‐Ju Lin, Chien‐Chen Lai, Tsuey‐Ching Yang, Fuu‐Jen Tsai, Suh‐Chin Wu, Chih‐Ho Lai, Ching-Ying Wang and Chang‐Hai Tsai. Their work appears in journals such as Virus Research, Viruses, Investigative Ophthalmology & Visual Science, Bioorganic & Medicinal Chemistry Letters and Biomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.